Bay Street News, November, 2024

Phase 1/2 dose escalation study to evaluate BriaCell’s personalized next generation immunotherapy treatment in metastatic breast cancer Bria-OTS™ to be […]

DISTRICT – WIDE POTENTIAL OF THE NIKOLAI ULTRAMAFIC INTRUSIONS HAS BEEN DEMONSTRATED HIGHLIGHTS Alaska Energy Metals received assay results from […]

Industry-defining business aircraft establishes new record-setting missions including essential city pairs from Miami to São Paulo, Tokyo to Los Angeles, […]

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a […]

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the “Company” or […]

[212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and […]

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), […]

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Leading global diversified professional services company Colliers (NASDAQ and TSX: CIGI) is proud […]

MONTREAL, Nov. 21, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) […]

MONCTON, New Brunswick, Nov. 21, 2024 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release […]